AngioDynamics Inc reports results for the quarter ended February 28 - Earnings Summary

• AngioDynamics Inc ANGO.OQ reported quarterly adjusted earnings of 3 cents​​ per share for the quarter ended February 28, higher than the same quarter last year, when the company reported EPS of -16 cents. The mean expectation of three analysts for the quarter was for a loss of 13 cents per share. Wall Street expected results to range from -14 cents to -11 cents per share.

• Revenue fell 4.2% to $72.00 million from a year ago; analysts expected $70.30 million.

• AngioDynamics Inc's reported EPS for the quarter was a loss of 11 cents​.

• The company reported a quarterly loss of $4.41 million.

• AngioDynamics Inc shares had risen by 2.9% this quarter and gained 5.5% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 14.7% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

• Wall Street's median 12-month price target for AngioDynamics Inc is $15.00

This summary was machine generated from LSEG data April 2 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)